NCRA vs ITRI

For growth investors, Itron, Inc.

(ITRI) is the stronger pick with -3. 0% revenue growth year-over-year, versus -35. 2% for Nocera, Inc. (NCRA). Itron, Inc. (ITRI) offers the better valuation at 12. 3x trailing P/E (13. 4x forward), making it the more compelling value choice. Analysts rate Itron, Inc. (ITRI) a "Hold" — based on 37 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Itron, Inc.

(ITRI) delivered a total return of -16. 3%, compared to -96. 6% for Nocera, Inc. (NCRA). Over 10 years, the gap is even starker: ITRI returned +77. 4% versus NCRA's -97. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Itron, Inc.

(ITRI) is the lower-risk stock at 1. 56β versus Nocera, Inc. 's 1. 68β — meaning NCRA is approximately 7% more volatile than ITRI relative to the S&P 500. On balance sheet safety, Itron, Inc. (ITRI) carries a lower debt/equity ratio of 74% versus 3% for Nocera, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Itron, Inc.

(ITRI) is pulling ahead at -3. 0% versus -35. 2% for Nocera, Inc. (NCRA). On earnings-per-share growth, the picture is similar: Itron, Inc. grew EPS 25. 7% year-over-year, compared to -11. 1% for Nocera, Inc.. Over a 3-year CAGR, ITRI leads at 9. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Itron, Inc.

(ITRI) is the more profitable company, earning 12. 7% net margin versus -25. 7% for Nocera, Inc. — meaning it keeps 12. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ITRI leads at 13. 5% versus -22. 3% for NCRA. At the gross margin level — before operating expenses — ITRI leads at 37. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Itron, Inc.

(ITRI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Nocera, Inc. (NCRA) carries a higher beta of 1. 68 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ITRI: +77. 4%, NCRA: -97. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (NCRA (Consumer Defensive) and ITRI (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: NCRA is a small-cap quality compounder stock; ITRI is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.